Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Pain 4Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain, Postoperative 2Agnosia 2Acute Pain 2Rectal Neoplasms 1Prostatic Neoplasms 1Otolaryngeal Cancer 1Lymphoma, Follicular 1Ileus 1Gastrointestinal Neoplasms 1Emergence Delirium 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Anxiety Disorders 1

Interventions

remimazolam 1Sugammadex 1Sodium Chloride 1Saline Solution 1Pyridostigmine Bromide 1Propofol 1Neuroleptanalgesia 1Nalbuphine 1Ketamine 1Injections 1Ibuprofen 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Emergence Delirium × Ketamine × Clear all
NCT05176119 2022-01-04

Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy

Ain Shams University

Phase 4 Completed
90 enrolled
LymphoidOther hematologic neoplasm

Emergence Delirium, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡